M1A.15
Lead-induced chronic gout, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced chronic gout in the hip is a rare form of gout caused by prolonged exposure to lead. This condition results in the accumulation of uric acid crystals in the hip joint, leading to inflammation, pain, and joint damage. It is linked to chronic lead poisoning, which can impair the body's ability to process uric acid normally. Recognizing this condition is important for proper diagnosis and management, especially in individuals with known lead exposure.
Causes & Symptoms
Clinical Causes: Prolonged exposure to lead, often from occupational sources such as mining, construction, plumbing, or manufacturing. Chronic lead poisoning leading to impaired renal function, which reduces uric acid excretion. Environmental exposure to lead contaminated water, soil, or air over time. Use of lead-containing products or medications that release lead into the body. Pre-existing kidney issues that decrease uric acid clearance, exacerbated by lead exposure.
Key Symptoms: Persistent joint pain in the hip, often worsening with activity. Swelling and tenderness around the affected hip joint. Reduced range of motion and joint stiffness. Chronic inflammation with possible formation of tophi or urate crystal deposits. Symptoms may be accompanied by signs of lead poisoning, such as fatigue, abdominal pain, and neurological symptoms in advanced cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory testing. Key approaches include: - Medical history review focusing on potential lead exposure. - Physical examination of the hip joint for swelling, tenderness, and range of motion. - Blood tests measuring uric acid levels and lead levels. - Imaging studies like X-rays to detect joint damage or tophi. - Joint fluid analysis to identify urate crystals. - Kidney function tests to assess lead impact on renal performance.
Treatment Protocols: Treatment aims to reduce uric acid levels, manage symptoms, and address lead toxicity. Typical strategies include: - Chelation therapy to remove excess lead from the body. - Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids to control inflammation and pain. - Uric acid-lowering agents like allopurinol or febuxostat. - Lifestyle modifications, including dietary changes to reduce purine intake. - Addressing environmental and occupational lead exposure to prevent further poisoning. - Regular monitoring of blood lead and uric acid levels. - In severe cases, joint interventions or surgical options may be considered to restore function and relieve pain.
Clinical Advice & FAQs
Billing Guidance
Is M1A.15 a billable ICD-10 code?
Yes, M1A.15 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.15?
Clinical documentation must specify the nature of Lead-induced chronic gout, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference